
Your search for high-quality, complimentary CME/CE stops right here. The courses below are presented by myCME, the continuing education engine in Haymarket Medical Network’s (HMN) expanding portfolio of clinical websites. Below you’ll find practice-relevant courses that carry valuable CME/CE credit. Simply click any link to get started earning credit on myCME.
Featured Courses
Immunoglobulin Replacement Therapies for PIDD | myCME
1.00 CME: PIDD patient presentations, disease and treatment burdens, and dosing and administration specifications for IVIG and SCIG therapies. Exp 8/12/23
New Opportunities in the Treatment of COVID-19 | myCME
1.50 CME: This course provides vital information on the treatment of active COVID-19 infection. Exp 9/1/23
HIV PrEP for the Nurse Practitioner: Pearls and Pitfalls | myCME
0.75 CNE: Experts examine types of patients who may benefit from PrEP, with strategies to encourage adherence and continued follow-up. Exp 9/29/2023
Managing Resistance in Heavily ART-Experienced People with HIV | myCME
0.75 CME CE: Faculty will present the latest information on the causes of ART resistance and medication non-adherence in patients with HIV and discuss the latest medication. Exp 1/18/24
Overcoming Gram-negative Bacterial Resistance | myCME
1.00 CME CPE: Reviews latest diagnostic techniques available for rapid identification of bacterial species and resistance phenotypes/genotypes. Exp 8/25/23
Vaccine Co-Administration in a COVID World | myCME
0.75 CME: This course provides vital information on the treatment of active COVID-19 infection and vaccinations. Exp 8/30/23
Serotypes and Implications of Pneumococcal Vaccinations | myCME
1.50 CME: Vital information on the impact of pneumococcal pneumonia and IPD, importance of serotypes, and updates on recent approvals and evidence. Exp 9/2/23
Simplifying Treatments for Ambulatory COVID-19 Patients | myCME
1.00 CME: The focus of this first of 3 modules is on diagnosis, testing and risk factors for progression to severe disease and provides vital information on the treatment of ambulatory patients with COVID-19. Exp 2/28/24
Treatment of Mild-to-Moderate COVID-19 in Those with a Risk of Progression to Severe Disease | myCME
1.25 CME: This course provides vital information on the treatment of ambulatory patients with COVID-19. Exp 3/31/24
COVID-19 Outpatient Treatment Recommendations | myCME
1.00 CME: This course provides vital information on the treatment of ambulatory patients with COVID-19. Exp 4/21/24
Herpes Zoster: Opportunities to Improve Vaccination Rates | myCME
1.00 CME CE: Multimedia journey of strategies and protocols for improved HZ vaccination rates to improve disease burden. Exp 5/2/24
Recurrent C. difficile and Microbiota-Based Biotherapies | myCME
1.25 CME: Clinicians will learn about the risk factors for C. diff recurrence, current guidelines, and treatment. Microbiota restoration therapies are discussed. Exp 9/7/23